Association between second-trimester sFlt-1/PlGF ratio and composite adverse neonatal outcome in patients with preeclampsia
{{output}}
Objectives: To investigate the predictive performance of the second-trimester soluble fms-like tyrosine kinase-1/placental growth factor (sFlt-1/PlGF) ratio for composite adverse neonatal outcome (CANO) in preeclampsia (PE). ... ...
